Asthma hospitalisation and mortality during the first wave of COVID-19
S. Smith (Glasgow, United Kingdom), A. Royle (Glasgow, United Kingdom), D. Jackson (London, United Kingdom), M. Levy (London, United Kingdom), N. Lee (Glasgow, United Kingdom), M. Shepherd (Glasgow, United Kingdom), F. Yang (Glasgow, United Kingdom), M. Armstrong (Glasgow, United Kingdom), L. Heaney (Belfast, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom)
Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Smith (Glasgow, United Kingdom), A. Royle (Glasgow, United Kingdom), D. Jackson (London, United Kingdom), M. Levy (London, United Kingdom), N. Lee (Glasgow, United Kingdom), M. Shepherd (Glasgow, United Kingdom), F. Yang (Glasgow, United Kingdom), M. Armstrong (Glasgow, United Kingdom), L. Heaney (Belfast, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom). Asthma hospitalisation and mortality during the first wave of COVID-19. 4056
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: